Targeting the Nrf2/Heme oxygenase-1 pathway can significantly increase oxidative stress in RCC and promote apoptosis and death of cancer cells (104), while Heme oxygenase-1 has a dual role in ferroptosis induction (105). The gene discussed is HMOX1; the disease is renal cell carcinoma.